Browsing Tag
Centers for Medicare and Medicaid Services
3 posts
PainChek just unlocked US Medicare reimbursement. Here’s what the ASX: PCK bull case looks like now
PainChek (ASX: PCK) has FDA clearance and a 30,000-bed US pipeline. Here's what the RTM reimbursement pathway means for retail investors watching PCK.
UnitedHealth Group (NYSE: UNH) faces April 21 earnings test after CMS win
UNH shares up ~10% after CMS finalises a 2.48% 2027 Medicare Advantage rate hike. Here is what retail investors need to know before April 21 earnings.
Will UroGen Pharma’s reimbursement tailwind in 2026 turn ZUSDURI into a category-defining cancer therapy?
UroGen Pharma sets $1B peak sales goal for ZUSDURI as permanent J-code from 2026 is expected to drive widespread adoption in outpatient urology settings.